Registration
PRIME POLICY GROUP for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
COVID-19 vaccine and therapy development and deployment
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEFAN BAILEY New | 2003-2004: Legislative Assistant, Rep. Baron Hill (IN-09); 2004-2005: Press Secretary/Legislative Director, Rep. Baron Hill (IN-09); 2005-2007: Legislative Director, Rep. Nick Rahall (WV-03) |
| EMILY AUSTEN KATZ New | 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH |
| RICH MEADE New | 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTRAZENECA PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.